全文获取类型
收费全文 | 136096篇 |
免费 | 9767篇 |
国内免费 | 222篇 |
专业分类
耳鼻咽喉 | 1291篇 |
儿科学 | 3857篇 |
妇产科学 | 2885篇 |
基础医学 | 21277篇 |
口腔科学 | 3754篇 |
临床医学 | 11331篇 |
内科学 | 27052篇 |
皮肤病学 | 2388篇 |
神经病学 | 13464篇 |
特种医学 | 5606篇 |
外国民族医学 | 20篇 |
外科学 | 17453篇 |
综合类 | 587篇 |
一般理论 | 122篇 |
预防医学 | 14922篇 |
眼科学 | 2219篇 |
药学 | 8233篇 |
中国医学 | 247篇 |
肿瘤学 | 9377篇 |
出版年
2023年 | 533篇 |
2021年 | 1623篇 |
2020年 | 1508篇 |
2019年 | 2180篇 |
2018年 | 2738篇 |
2017年 | 2339篇 |
2016年 | 2552篇 |
2015年 | 2830篇 |
2014年 | 3893篇 |
2013年 | 5106篇 |
2012年 | 7852篇 |
2011年 | 7933篇 |
2010年 | 4158篇 |
2009年 | 4320篇 |
2008年 | 7086篇 |
2007年 | 7297篇 |
2006年 | 7046篇 |
2005年 | 6665篇 |
2004年 | 5753篇 |
2003年 | 5490篇 |
2002年 | 4936篇 |
2001年 | 4861篇 |
2000年 | 4804篇 |
1999年 | 4293篇 |
1998年 | 1616篇 |
1997年 | 1336篇 |
1996年 | 1399篇 |
1995年 | 1243篇 |
1994年 | 1157篇 |
1993年 | 1073篇 |
1992年 | 2982篇 |
1991年 | 2721篇 |
1990年 | 2607篇 |
1989年 | 2429篇 |
1988年 | 2243篇 |
1987年 | 1961篇 |
1986年 | 1867篇 |
1985年 | 1779篇 |
1984年 | 1254篇 |
1983年 | 1089篇 |
1982年 | 579篇 |
1981年 | 509篇 |
1980年 | 451篇 |
1979年 | 947篇 |
1978年 | 568篇 |
1977年 | 499篇 |
1974年 | 488篇 |
1973年 | 486篇 |
1972年 | 475篇 |
1971年 | 452篇 |
排序方式: 共有10000条查询结果,搜索用时 22 毫秒
1.
Pieternella C. Bots-VantSpijker Claar D. van der Maarel-Wierink Jos M.G.A. Schols Josef J.M. Bruers 《International dental journal》2022,72(2):169-178
BackgroundResearch into oral health care for older people has shown that dental care in general decreases with increasing age and frailty and, therefore, oral health care provision may be complex. The aim of this study is to identify the oral health care dentists provide to community-dwelling older people and which barriers they experience in doing this.MethodsIn this cross-sectional study, a representative sample of dentists in the Netherlands was asked to prospectively select one older patient and describe this patient using a specially developed registration form; the patient was requested to fill out a questionnaire. The relationship between experienced barriers in providing oral health care to older patients and characteristics of the dentists and the patients was studied by means univariate and multivariate logistic regression analysis.ResultsIn total, 923 dentists were asked to participate in the study. Data were available for 39.4% dentist–patient pairs. In most cases (87.4%), oral health care was focussed on conservation of the dentition. In all, 14.0% of the dentists experienced barriers in providing oral health care for older people. Some patient factors increase the risk of experiencing barriers, eg, the more difficult behaviour of older patients and the greater disease burden.ConclusionsOral health care was mostly focussed on conservation of the dentition, and dentists especially experience barriers in oral health provision to older patients if they are already frail. 相似文献
2.
van Bunningen R. H. Dijkstra P. U. Dieters A. van der Meer W. J. Kuijpers-Jagtman A. M. Ren Y. 《Clinical oral investigations》2022,26(2):1543-1550
Clinical Oral Investigations - To analyze differences in variation of orthodontic diagnostic measurements on lateral cephalograms reconstructed from ultra low dose-low dose (ULD-LD) cone beam... 相似文献
3.
Simone Oerlemans PhD Fabio Efficace PhD Charalampia Kyriakou PhD MD Ana Carolina Freitas PhD MD Omar Shamieh PhD MD Carien L. Creutzberg PhD MD Jens Lehmann PhD Duska Petranovic PhD MD Eva Nagele PhD Anne Bredart PhD Dong Dong PhD Christian W. Scholz PhD MD Giovanni Caocci PhD MD Stefano Molica PhD MD Laimonas Griskevicius PhD MD Aliki Xochelli PhD MD Jacobien M. Kieffer PhD Joost A. Agelink van Rentergem PhD Waleed Alrjoub BSN Anja Mueller PhD Maria Gomes Da Silva PhD MD Filipa Alves da Costa PhD PharmD Sandra Malak PhD MD Kim Cocks PhD Lonneke V. van de Poll-Franse PhD the EORTC Quality of Life Group 《Cancer》2023,129(17):2727-2740
Background
Health-related quality of life (HRQOL) is a critical aspect to consider when making treatment decisions for patients with non-Hodgkin-lymphoma (NHL). This international study by the European Organisation for Research and Treatment of Cancer (EORTC) tested the psychometric properties of two newly developed measures for patients with high-grade (HG)- and low-grade (LG)-NHL: the EORTC QLQ-NHL-HG29 and the EORTC QLQ-NHL-LG20 to supplement the core questionnaire (EORTC QLQ-C30).Methods
Overall, 768 patients with HG-NHL (N = 423) and LG-NHL (N = 345) from 12 countries completed the QLQ-C30, QLQ-NHL-HG29/QLQ-NHL-LG20 and a debriefing questionnaire at baseline, and a subset at follow-up for either retest (N = 125/124) or responsiveness to change (RCA; N = 98/49).Results
Confirmatory factor analysis showed an acceptable to good fit of the 29 items of the QLQ-NHL-HG29 on its five scales (symptom burden [SB], neuropathy, physical condition/fatigue [PF], emotional impact [EI], and worries about health/functioning [WH]), and of the 20 items of the QLQ-NHL-LG20 on its four scales (SB, PF, EI, and WH). Completion took on average 10 minutes. Test–retest reliability, convergent validity, known-group comparisons, and RCA find satisfactory results of both measures. A total of 31%–78% of patients with HG-NHL and 22%–73% of patients with LG-NHL reported symptoms and/or worries (e.g., tingling in hands/feet, lack of energy, and worries about recurrence). Patients reporting symptoms/worries had substantially lower HRQOL compared to those without.Discussion
The use of the EORTC QLQ-NHL-HG29 and QLQ-NHL-LG20 questionnaires in clinical research and practice will provide clinically relevant data to better inform treatment decision-making.Plain language summary
- The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group developed two questionnaires.
- These questionnaires measure health-related quality of life.
- The questionnaires are for patients with high-grade or low-grade non-Hodgkin lymphoma.
- They are called the EORTC QLQ-NHL-HG29 and QLQ-NHL-LG20.
- The questionnaires are now internationally validated.
- This study demonstrates that the questionnaires are reliably and valid, which are important aspects of a questionnaire.
- The questionnaires can now be used in clinical trials and practice.
- With the information gathered from the questionnaires, patients and clinicians can better evaluate treatments and discuss the best choice for a patient.
4.
5.
Thom T. J. Veeger Nienke M. van de Velde Kevin R. Keene Erik H. Niks Melissa T. Hooijmans Andrew G. Webb Jurriaan H. de Groot Hermien E. Kan 《NMR in biomedicine》2022,35(7):e4691
In Becker muscular dystrophy (BMD), muscle weakness progresses relatively slowly, with a highly variable rate among patients. This complicates clinical trials, as clinically relevant changes are difficult to capture within the typical duration of a trial. Therefore, predictors for disease progression are needed. We assessed if temporal increase of fat fraction (FF) in BMD follows a sigmoidal trajectory and whether fat fraction at baseline (FFbase) could therefore predict FF increase after 2 years (ΔFF). Thereafter, for two different MR-based parameters, we tested the additional predictive value to FFbase. We used 3-T Dixon data from the upper and lower leg, and multiecho spin-echo MRI and 7-T 31P MRS datasets from the lower leg, acquired in 24 BMD patients (age: 41.4 [SD 12.8] years). We assessed the pattern of increase in FF using mixed-effects modelling. Subsequently, we tested if indicators of muscle damage like standard deviation in water T2 (stdT2) and the phosphodiester (PDE) over ATP ratio at baseline had additional value to FFbase for predicting ∆FF. The association between FFbase and ΔFF was described by the derivative of a sigmoid function and resulted in a peak ΔFF around 0.45 FFbase (fourth-order polynomial term: t = 3.7, p < .001). StdT2 and PDE/ATP were not significantly associated with ∆FF if FFbase was included in the model. The relationship between FFbase and ∆FF suggests a sigmoidal trajectory of the increase in FF over time in BMD, similar to that described for Duchenne muscular dystrophy. Our results can be used to identify muscles (or patients) that are in the fast progressing stage of the disease, thereby facilitating the conduct of clinical trials. 相似文献
6.
Bertrand Isidor Frédéric Ebstein Anna Hurst Marie Vincent Ingrid Bader Natasha L. Rudy Benjamin Cogne Johannes Mayr Anja Brehm Caleb Bupp Kathryn Warren Carlos A. Bacino Amanda Gerard Judith D. Ranells Kay A. Metcalfe Yolande van Bever Yong-Hui Jiang Bryce A. Mendelssohn PaweƗ Stankiewicz 《Genetics in medicine》2022,24(1):179-191
PurposeHaploinsufficiency of PSMD12 has been reported in individuals with neurodevelopmental phenotypes, including developmental delay/intellectual disability (DD/ID), facial dysmorphism, and congenital malformations, defined as Stankiewicz-Isidor syndrome (STISS). Investigations showed that pathogenic variants in PSMD12 perturb intracellular protein homeostasis. Our objective was to further explore the clinical and molecular phenotypic spectrum of STISS.MethodsWe report 24 additional unrelated patients with STISS with various truncating single nucleotide variants or copy-number variant deletions involving PSMD12. We explore disease etiology by assessing patient cells and CRISPR/Cas9-engineered cell clones for various cellular pathways and inflammatory status.ResultsThe expressivity of most clinical features in STISS is highly variable. In addition to previously reported DD/ID, speech delay, cardiac and renal anomalies, we also confirmed preaxial hand abnormalities as a feature of this syndrome. Of note, 2 patients also showed chilblains resembling signs observed in interferonopathy. Remarkably, our data show that STISS patient cells exhibit a profound remodeling of the mTORC1 and mitophagy pathways with an induction of type I interferon-stimulated genes.ConclusionWe refine the phenotype of STISS and show that it can be clinically recognizable and biochemically diagnosed by a type I interferon gene signature. 相似文献
7.
8.
Shavadia Jay S. Alemayehu Wendimagegn deFilippi Christopher Westerhout Cynthia M. Tromp Jasper Granger Christopher B. Armstrong Paul W. van Diepen Sean 《Journal of thrombosis and thrombolysis》2022,53(4):841-850
Journal of Thrombosis and Thrombolysis - Early prediction of significant morbidity or mortality in patients with acute ST-segment elevation myocardial infarction (STEMI) represents an unmet... 相似文献
9.
Clark Hannah Rana Rezwanul Gow Jeff Pearson Melissa van der Touw Tom Smart Neil 《Heart failure reviews》2022,27(2):559-572
Heart Failure Reviews - Heart failure with preserved ejection fraction (HFpEF) is problematic to treat, with guidelines for HFpEF management concentrated on treating prevalent comorbidities. The... 相似文献
10.
Rohde Sofie Muslem Rahatullah Kaya Emrah Dalinghaus Michel van Waning Jaap I. Majoor-Krakauer Danielle Towbin Jeffery Caliskan Kadir 《Heart failure reviews》2022,27(1):15-28
Heart Failure Reviews - Noncompaction cardiomyopathy (NCCM) is a disease characterized by hypertrabeculation, commonly hypothesized due to an arrest in compaction during fetal development. In 2006,... 相似文献